Author Archives: Steve Bryson PhD

High-dose Cranberry Juice Shows Potential to Protect Brain Cells

Concentrated cranberry juice eased signs associated with Parkinson’s disease in a chemically induced rat model, but its long-term use at high dose may affect the survival of brain cells, a study suggests. Further research is needed to determine an optimal dose of a cranberry juice concentrate with neuroprotective properties,…

No Causal Link Between IBD, Parkinson’s in Large-scale Analysis

No causal relationship was identified between Parkinson’s disease and inflammatory bowel disease (IBD) or its major subtypes, Crohn’s disease and ulcerative colitis, in a large-scale European genetic analysis. More research is needed to determine whether other types of intestinal inflammation or unknown inflammatory mediators contribute to developing Parkinson’s,…

Hand Movement Triggers Eyeblinks in Parkinson’s Patient

Hand movements induced eyeblinks in a 70-year-old man with Parkinson’s disease, a case study reported for the first time. Although more studies are necessary, researchers suggest that eyeblink bursts induced by hand movements may be regarded as a potential hallmark of Parkinson’s disease. The case study, “…

Peripheral Neuropathy Can Be Evident, Levodopa Link Possible

Damage to certain nerve fibers in the extremities, known as peripheral neuropathy, was evident in some people with Parkinson’s disease, including those at early disease stages, a study reported. Findings in this work, which used a sensitive electrophysiological device to examine nerves, also suggested that peripheral neuropathy was related…

Phase 2 Trial of NLY01 in Slowing Disease Progression Fully Enrolled

Enrollment is complete in the Phase 2 study evaluating Neuraly‘s NLY01, an investigational disease-modifying agent designed to slow or stop Parkinson’s disease progression by protecting nerve cells and limiting neuroinflammation. Top-line results from the trial, which enrolled 255 people with early Parkinson’s at 60 sites in the U.S. and Canada,…

Patients Prefer Telehealth Over Visits in Person for Certain Services

Telehealth services during the COVID-19 pandemic was perceived to be a good alternative to in-person healthcare appointments among people with Parkinson’s disease, according to an anonymous survey. Respondents said telehealth reduced travel, was more convenient, was suitable for follow-up appointments, and was preferred for speech-language pathology and mental health…